RE:RE:2021-06-24 17:45 ET - News ReleaseDidn't take long to have to file a correction: GrowMax Announces Filing of Early Warning Report in Connection with Beyond Medical and Correction to News Release Issued on June 24, 2021 Vancouver, June 29, 2021 GrowMax Resources Corp. (TSXV: GRO) (GrowMax or the Company) announces that it has filed an early warning report in respect of its holdings in Beyond Medical Technologies Inc. (Beyond Medical). The common shares of Beyond Medical (Shares) are listed on the Canadian Securities Exchange (the CSE) under the symbol DOCT. On June 28, 2021, the Company disposed 1,500,000 Shares through the facilities of the CSE (the Disposition). Following the Disposition, the Company holds an aggregate of 7,000,000 Shares, representing approximately 8.8% of the issued and outstanding Shares of Beyond Medical on non-diluted basis and 16.33% on a partially diluted basis. The Company intends to evaluate its investment in Beyond Medical and to increase or decrease its security holdings from time to time as it may determine appropriate for investment purposes. This press release is being issued in accordance with National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues in connection with the filing of an early warning report dated June 28, 2021. The early warning report has been filed on the System for Electronic Document Analysis and Review (SEDAR) under Beyond Medicals issuer profile. To obtain a copy of the early warning report filed by GrowMax, please contact Kal Malhi, Chief Executive Officer at 604-805-4602 or refer to Beyond Medicals issuer profile on SEDAR at www.sedar.com. The Company also announces a correct to its news release entitled GrowMax Provides Corporate Update dated June 24, 2021 (the Initial Press Release). The Initial Press Release incorrectly stated the number of common shares of Beyond Medical that the Company purchased in February and March 2021. On February 25, 2021 the Company purchased 8,000,000 units of Beyond Medical for a total cost of $1,000,000. It also purchased on the same day 100,000 Shares for a total cost of $19,000 and another 100,000 Share for a total cost of $21,000. On March 1, 2021, the Company purchased an additional 100,000 Shares for a total cost of $24,000 and 200,000 Shares for a total cost of $49,000. On June 28, 2021, the Company sold 1,500,000 Shares for $75,000. Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. It is listed on the Canadian Securities Exchange under the symbol DOCT. The acquisitions and sale of the common shares of Beyond Medical completed by GrowMax after February 25, 2021 are considered related party transactions within the meaning of Multilateral Instrument 61- 101 - Protection of Minority Security holders in Special Transactions (MI 61-101) as GrowMax is considered an insider of Beyond Medical. However, such transactions are exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of any securities issued to the GrowMax nor the consideration paid by GrowMax exceeded 25% of GrowMaxs market capitalization. For more information about GrowMax, please contact: Kal Malhi Chief Executive Officer 604-805-4602